Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 14th Annual BIO CEO & Investor Conference will be webcast and may be accessed at www.hgsi.com.

A member of Human Genome Sciences’ senior management team will present a corporate overview on Tuesday, February 14, 2012, at 11:30 AM Eastern time. Investors interested in listening to the live webcast may want to log on before the presentation begins to download any software required. The archive of the presentation will be available for several days following the event.

ABOUT HUMAN GENOME SCIENCES

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease.

For more information about HGS, please visit the Company’s web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinicaltrialsinfo@hgsi.com or by calling HGS at (240) 314-4430.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. Other trademarks referenced are the property of their respective owners.